Gene · 1270
Papers4,359
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,359
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Palmitoylation-dependent control of JAK1 kinase signaling governs responses to neuropoietic cytokines and survival in DRG neurons. | J Biol Chem | 2023 | 37356718 | PubTator, text mining | PubMed |
| Developmental Expression of the Cell Cycle Regulator p16INK4a in Retinal Glial Cells: A Novel Marker for Immature Ocular Astrocytes? | J Histochem Cytochem | 2023 | 37350564 | PubTator, text mining | PubMed |
| Astrocytic uptake of neuronal corpses promotes cell-to-cell spreading of tau pathology. | Acta Neuropathol Commun | 2023 | 37330529 | PubTator, text mining | PubMed |
| From neurodevelopment to neurodegeneration: utilizing human stem cell models to gain insight into Down syndrome. | Front Genet | 2023 | 37323671 | PubTator, text mining | PubMed |
| Early molecular layer interneuron hyperactivity triggers Purkinje neuron degeneration in SCA1. | Neuron | 2023 | 37321222 | PubTator, text mining | PubMed |
| Optic nerve diseases and regeneration: How far are we from the promised land? | Clin Exp Ophthalmol | 2023 | 37317890 | PubTator, text mining | PubMed |
| Differentially Expressed Tear Proteins in Sjögren's Syndrome Keratoconjunctivitis Sicca. | Transl Vis Sci Technol | 2023 | 37310735 | PubTator, text mining | PubMed |
| Construction of a prognostic model for triple-negative breast cancer based on immune-related genes, and associations between the tumor immune microenvironment and immunological therapy. | Cancer Med | 2023 | 37306188 | PubTator, text mining | PubMed |
| Pro- and Anti-Inflammatory Prostaglandins and Cytokines in Humans: A Mini Review. | Int J Mol Sci | 2023 | 37298597 | PubTator, text mining | PubMed |
| Bridging Gaps in Peripheral Nerves: From Current Strategies to Future Perspectives in Conduit Design. | Int J Mol Sci | 2023 | 37298122 | PubTator, text mining | PubMed |
| The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics. | Healthcare (Basel) | 2023 | 37297725 | PubTator, text mining | PubMed |
| Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance. | BMC Cancer | 2023 | 37291514 | PubTator, text mining | PubMed |
| Neuronal chemokines: new insights into neuronal communication after injury. | Neural Regen Res | 2023 | 37282457 | PubTator, text mining | PubMed |
| deCLUTTER2+ - a pipeline to analyze calcium traces in a stem cell model for ventral midbrain patterned astrocytes. | Dis Model Mech | 2023 | 37260295 | PubTator, text mining | PubMed |
| Alpha-synuclein-associated changes in PINK1-PRKN-mediated mitophagy are disease context dependent. | Brain Pathol | 2023 | 37259617 | PubTator, text mining | PubMed |
| Human induced neural stem cells support functional recovery in spinal cord injury models. | Exp Mol Med | 2023 | 37258581 | PubTator, text mining | PubMed |
| Photobiomodulation therapy activates YAP and triggers proliferation and dedifferentiation of Müller glia in mammalian retina. | BMB Rep | 2023 | 37254570 | PubTator, text mining | PubMed |
| Herpes endotheliitis following laser-assisted in situ keratomileusis and photorefractive keratectomy. | Taiwan J Ophthalmol | 2023 | 37252172 | PubTator, text mining | PubMed |
| Heparin-Based Hydrogel Micropatches with Human Adipose-Derived Stem Cells: A Promising Therapeutic Approach for Neuropathic Pain Relief. | Biomedicines | 2023 | 37239107 | PubTator, text mining | PubMed |
| Multipotent Mesenchymal Stem Cell-Based Therapies for Spinal Cord Injury: Current Progress and Future Prospects. | Biology (Basel) | 2023 | 37237467 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1270/papers?page=18